StockData
Edwards Lifesciences Corp logo

Edwards Lifesciences Corp (EW) income statement

EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3060% above fair value
$105.23−0.20 (-0.19%)

Close on Nov 18, 2026Market cap $60.65BP/E 60.5Yield –

Edwards Lifesciences Corp income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
77.8%
Operating margin
22.3%
Net margin
15.4%
Return on equity, FY2025
10.6%

Financial strength

Current ratio
4.52
Debt to equity
0.06
Debt to assets
4.3%
Cash to current liabilities
192.8%

Valuation

P/E ratio
60.5
Price to sales
9.31
Price to book
5.71
Dividend yield
–

See a number that looks wrong?